ACE2 and acute respiratory distress syndrome: Conversely, a beneficial role of ACE2 in COVID-19 has been reported, as a recent pilot clinical trial in patients with acute respiratory distress syndrome demonstrated the promising role of recombinant human ACE2 in attenuating the acute lung injury [18].